Source: Scientific Reports. Unidades: FM, ICB
Subjects: IMUNOLOGIA, ANTINEOPLÁSICOS, LEUCEMIA MIELOIDE AGUDA, APOPTOSE, EPIGÊNESE GENÉTICA, BIOMARCADORES, PROLIFERAÇÃO CELULAR, CÉLULAS CULTIVADAS DE TUMOR
ABNT
LATÂNCIA, Marcela Teatin et al. Combinational BET and mTOR inhibition unveils EGR1 as acute myeloid leukemia prognostic biomarker. Scientific Reports, v. 15, 2025Tradução . . Disponível em: https://doi.org/10.1038/s41598-025-24366-0. Acesso em: 28 abr. 2026.APA
Latância, M. T., Silva, W. F. da, Jardim, E. B., Terra, F. F., Asprino, P. F., Pereira, W. de O., et al. (2025). Combinational BET and mTOR inhibition unveils EGR1 as acute myeloid leukemia prognostic biomarker. Scientific Reports, 15. doi:10.1038/s41598-025-24366-0NLM
Latância MT, Silva WF da, Jardim EB, Terra FF, Asprino PF, Pereira W de O, Buzatto VC, Galante PAF, Inoue L, Fonseca ARBM, Kimmemgs TN, Rodrigues CA, Rocha VG, Novis Y, Reis LFL, Amano MT, Câmara NOS, Lepique AP. Combinational BET and mTOR inhibition unveils EGR1 as acute myeloid leukemia prognostic biomarker [Internet]. Scientific Reports. 2025 ; 15[citado 2026 abr. 28 ] Available from: https://doi.org/10.1038/s41598-025-24366-0Vancouver
Latância MT, Silva WF da, Jardim EB, Terra FF, Asprino PF, Pereira W de O, Buzatto VC, Galante PAF, Inoue L, Fonseca ARBM, Kimmemgs TN, Rodrigues CA, Rocha VG, Novis Y, Reis LFL, Amano MT, Câmara NOS, Lepique AP. Combinational BET and mTOR inhibition unveils EGR1 as acute myeloid leukemia prognostic biomarker [Internet]. Scientific Reports. 2025 ; 15[citado 2026 abr. 28 ] Available from: https://doi.org/10.1038/s41598-025-24366-0
